Vertex Announces US FDA Approval of ALYFTREK™, a Once-Daily …
Dec 20, 2024 · The company has approved medicines that treat the underlying causes of multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continues to advance clinical and research programs in …
Vertex Pharmaceuticals Sets Sight on Expanding Portfolio with …
13 hours ago · If approved, it would give Vertex Pharmaceuticals a significant new revenue source beyond cystic fibrosis, especially as income from Casgevy remains low in the near term, helping to diversify its ...
Vertex Pharmaceuticals Sets Sight on Expanding Portfolio
12 hours ago · If approved, it would give Vertex Pharmaceuticals a significant new revenue source beyond cystic fibrosis, especially as income from Casgevy remains low in the near term, helping to diversify its ...
Vertex secures two FDA wins for cystic fibrosis, both with boxed ...
Dec 23, 2024 · Vertex Pharmaceuticals has secured two simultaneous US Food and Drug Administration (FDA) approvals for cystic fibrosis (CF) treatments, but both therapies come with boxed warnings for potential drug-induced liver injury including liver failure.
Vertex's Cystic Fibrosis Drug Alyftrek Gets FDA Approval
Dec 20, 2024 · (RTTNews) - Vertex Pharmaceuticals Inc. (VRTX) Friday announced that the U.S. Food and Drug Administration (FDA) has approved Alyftrek for treatment of cystic fibrosis.
News & Events - Vertex Pharmaceuticals
Jul 2, 2024 · The company has approved medicines that treat the underlying causes of multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continues to advance clinical and research programs in …
Vertex Announces U.S. FDA Approval for Trikafta …
BOSTON--(BUSINESS WIRE)--Dec. 20, 2024-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) ... About Cystic Fibrosis. Cystic fibrosis (CF) is a rare, life-shortening genetic disease affecting more than 92,000 people globally. ... Subscribe to our newsletter for the latest medication news, new drug approvals and FDA alerts.
Vertex' Trikafta Gets Expanded FDA Approval For Cystic Fibrosis ...
Dec 20, 2024 · (RTTNews) - Vertex Pharmaceuticals (VRTX) said Friday the U.S. Food and Drug Administration expanded its approval of a cystic fibrosis treatment, encompassing more patients with different...
Vertex Gets Expanded FDA Approval for Cystic Fibrosis Treatment
Dec 20, 2024 · Vertex Pharmaceuticals said Friday the U.S. Food and Drug Administration expanded its approval of a cystic fibrosis treatment, encompassing more patients with different types of mutations of...
FDA approves next-generation triple therapy for cystic fibrosis
2 days ago · NEWS IN BRIEF ; 13 January 2025; FDA approves next-generation triple therapy for cystic fibrosis ... innovate and to improve the lives of people living with cystic fibrosis,” said Vertex CEO ...